MedPath

Early Versus Conventional Cessation of Hydrocortisone in Septic Shock

Phase 2
Recruiting
Conditions
Hydrocortisone
Muscle Weakness
Septic Shock
Adverse Event
Hyperglycemia
Hypernatremia
Superimposed Infection
Interventions
Registration Number
NCT05818826
Lead Sponsor
Mahidol University
Brief Summary

Septic shock is one of the causes of death in ICU and hospital. Refractory shock is the problem which healthcare providers should recognize though it is difficult to handle with. The corticosteroid called hydrocortisone is one of the treatment in refractory septic shock which requires vasopressor to maintain blood pressure. In recovery phase of septic shock and weaning off vasopressor, there is no definite way to taper off hydrocortisone.

Detailed Description

According to secondary outcomes of several studies analyzed in systemic review was shown adverse events from corticosteroid uses including hyperglycemia, hypernatremia, muscle weakness, and superimposed infection. This trials will compare composite adverse events in early versus conventional cessation of hydrocortisone in septic shock.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Patient >= 18 years old
  • Diagnosis Septic shock from the definition of SEPSIS III criteria in intensive care unit or medicine ward or surgical ward at Siriraj hospital
  • Received at least 1 catecholamines and hydrocortisone at least 200 mg/d
  • Maintain mean arterial pressure >= 65 mmHg even if titrate down catecholamines until low dose (<=0.1 mcg/kg/min)
Exclusion Criteria
  • Patient sign Do not resuscitation and terminally ill
  • Pregnancy
  • Need long term steroid use due to other medical condition

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
early cessation groupnormal saline solutionThe pharmacist uses 100 ml of normal saline solution, packed out in the same format, dose, and administration of the drug were exactly the same as in the conventional cessation group. The experimental starts after required dose of vasopressor less than 0.1 mcg/kg/min. The nurse serially records capillary blood glucose and serum sodium following the doctor's order.
conventional cessation groupHydrocortisone and normal saline solutionThe pharmacist prepared hydrocortisone and normal saline solution 100 ml starts dose at least 200 mg/day according to doctor's order after patient meets the criteria of refractory septic shock then continues conventional cessation of hydrocortisone according to doctor's order after required dose of vasopressor less than 0.1 mcg/kg/min. The nurse serially records capillary blood glucose and serum sodium following the doctor's order.
Primary Outcome Measures
NameTimeMethod
Composite adverse events of early versus conventional cessation of hydrocortisonewithin 14 days after randomization or until discharge from hospital, whichever came first

including level of capillary blood glucose \>= 180mg/dL(Hyperglycemia) , Plasma level of sodium\>= 150mmol/L(Hypernatremia), new onset of infection , and neuromuscular weakness(muscular impairment rating scale\>1

Secondary Outcome Measures
NameTimeMethod
Number of participants with New onset of infection within 28 days28 days

Number of participants with New onset of infection within 28 days

Number of participants with Alive days in 28 days with free renal replacement therapy28 days after randomization or until discharge from hospital, whichever came first

Number of participants who survive in 28 days with free mechanical ventilator

Number of participants with Alive days in 28 days with free organ supports28 days after randomization or until discharge from hospital, whichever came first

Number of participants who survive in 28 days with free mechanical ventilator

Number of participants with capillary blood glucose ≥ 150 mg/dLwithin 14 days after randomization or until discharge from hospital, whichever came first

Number of participants with capillary blood glucose ≥ 150 mg/dL

Duration of ICU length of stay14 days after first dose hydrocortisone or until discharge from hospital, whichever came first

Duration measured as days from randomization until discharge from ICU

Level of minimum and maximum mean arterial pressurewithin 14 days after randomization or until discharge from hospital, whichever came first

Level of minimum and maximum mean arterial pressure until 14 days after randomization or until hospital discharge

Number of participants with hypoglycemiawithin 14 days after randomization or until discharge from hospital, whichever came first

Number of participants with capillary blood glucose \< 80 mg/dL

Time of vasopressor reinitiation until 14 day after randomization or until hospital dischargewithin 14 days after randomization or until discharge from hospital, whichever came first

Duration measured as hours from off vasopressor until re-initiation at least 0.05 mcg/kg/min until 14 day after randomization or until hospital discharge

Number of participants with Lung injury score at day 1, day 3, day 7 after first dose hydrocortisone7 days after randomization or until discharge from hospital, whichever came first

Number of participants with Lung injury score at day1, day3, day7 after first dose hydrocortisone

Number of participants with 28-day mortality from any cause or until discharge from hospital28-day mortality from any cause start until 28 day after randomization or until discharge from hospital, whichever came first

death from any cause until 28-day after randomization or until discharge from hospital

Concentration of insulin needed due to hyperglycemiawithin 14 days after randomization or until discharge from hospital, whichever came first

Total insulin used to lower capillary blood sugar if level of glucose more than 180 mg/dL

Time to need of fluid boluswithin 14 days after randomization or until discharge from hospital, whichever came first

Duration measured as hours from randomization until fluid bolus at least 250 ml in 10-15 minutes until 14 day after randomization or until hospital discharge

Time to reversal of shockwithin 14 days after first dose of hydrocortisone or until discharge from hospital, whichever came first

Duration measured as hours from randomization until off vasopressor

Duration of Ventilator free day14 days after first dose hydrocortisone or until discharge from hospital, whichever came first

Duration measured as hours from off ventilator until on ventilator or reintubation

Number of participants with Alive days in 28 days with free mechanical ventilator28 days after randomization or until discharge from hospital, whichever came first

Number of participants who survive in 28 days with free mechanical ventilator

Trial Locations

Locations (1)

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath